In Myriad, Did Supreme Court Confuse Its Own Precedent?

Law360, New York (August 5, 2013, 1:43 PM EDT) -- On June 13, 2013, the United States Supreme Court issued its long-awaited decision in Association for Molecular Pathology v. Myriad Genetics Inc., and held that isolated genes are not patent eligible subject matter under 35 U.S.C. § 101. 569 U.S. ___, slip. op. at 13, 17 (2013). To reach this conclusion, the court relied on Funk Brothers Seed Co. v. Kalo Inoculant Co., 333 U.S. 127 (1948), a case in which a patent for a mixture of bacteria was held invalid because the mixture “fell short...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.